Neuroimaging adolescents with depression in a middle-income country:feasibility of an fMRI protocol and preliminary results by Battel, Lucas et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1590/1516-4446-2019-0508
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Battel, L., Swartz, J., Anes, M., Manfro, P. H., Rohde, L. A., Viduani, A., ... Kieling, C. (2019). Neuroimaging
adolescents with depression in a middle-income country: feasibility of an fMRI protocol and preliminary results.
Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2019-0508
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. Jul. 2020
  
http://dx.doi.org/10.1590/1516-4446-2019-0508 
ORIGINAL ARTICLE 
Neuroimaging adolescents with depression in a middle-income country: feasibility of an 
fMRI protocol and preliminary results 
 
Running title even page: Battel L et al. 
Running title odd page: Neuroimaging adolescent depression in Brazil 
Footer: Braz J Psychiatry. 2019;00(00) 
 
Lucas Battel,1,2 Johnna Swartz,3 Mauricio Anes,4 Pedro H. Manfro,1,2 Luis A. Rohde,1,2 Anna 
Viduani,1,2 Valeria Mondelli,5 Christian Kieling1,2(iD) 
 
1 Departamento de Psiquiatria, Universidade Federal do Rio Grande do Sul (UFRGS), Porto 
Alegre, RS, Brazil. 2 Serviço de Psiquiatria da Infância e Adolescência, Hospital de Clínicas de 
Porto Alegre (HCPA), Porto Alegre, RS, Brazil. 3 Department of Human Ecology, University of 
California, Davis, CA, USA. 4 Departamento de Física Médica e Radioproteção, HCPA, 
UFRGS, Porto Alegre, RS, Brazil. 5 Department of Psychological Medicine, Institute of 
Psychiatry, Psychology & Neuroscience, King’s College London, London, UK. (iD) 
<OrcID>https://orcid.org/0000-0001-7691-4149</OrcID> 
Correspondence: Christian Kieling, Departamento de Psiquiatria, Serviço de Psiquiatria da 
Infância e Adolescência, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio 
Grande do Sul, Rua Ramiro Barcelos, 2350, 400N, CEP 90035-903, Porto Alegre, RS, Brazil.  
Email: ckieling@ufrgs.br 
Submitted Apr 03 2019, accepted Apr 24 2019. 
How to cite this article: Battel L, Swartz J, Anes M, Manfro PH, Rohde LA, Viduani A et al. 
Neuroimaging adolescents with depression in a middle-income country: feasibility of fMRI data 
collection and preliminary results. Braz J Psychiatry. 2019;00:000-000. 
http://dx.doi.org/10.1590/1516-4446-2019-0508 
 
Abstract 
Objective: To test the feasibility and to present preliminary results of a neuroimaging protocol to 
evaluate adolescent depression in a middle-income setting. 
Methods: We assessed psychotropic medication-free adolescents (age range 14-16 years) with a 
diagnosis of major depressive disorder (MDD). Participants underwent a comprehensive clinical 
evaluation and both structural and functional magnetic resonance imaging (fMRI). In this pilot 
study, a preliminary single-group analysis of resting-state fMRI (rs-fMRI) data was performed, 
with a focus on the default mode network (DMN), cognitive control network (CCN), and 
salience network (SN).  
Results: The sample included 29 adolescents with MDD (mean age 16.01, SD 0.78) who 
completed the protocol. Only two participants were excluded due to MRI quality issues (head 
movement), and were not included in the analyses. The scans showed significant connectivity 
between the medial prefrontal cortex and posterior cingulate cortex (DMN), the ACC and 
anterior insula (SN), and the lateral prefrontal cortex and dorsal parietal cortex (CCN).  
Conclusion: We demonstrated the feasibility of implementing a complex neuroimaging protocol 
in a middle-income country. Further, our preliminary rs-fMRI data revealed patterns of resting-
  
state connectivity consistent with prior research performed in adolescents from high-income 
countries. 
Keywords: Depression; adolescent; neuroimaging  
 
Introduction 
Major depressive disorder (MDD) in youth is a highly prevalent and comorbid condition, 
and a leading cause of disease burden1 with a high rate of recurrence.2 Furthermore, adolescence 
is a period of heightened neuroplasticity, encompassing profound developmental changes with 
important alterations to both the structure and function of the brain.5 In addition, adolescence is a 
time of increased emergence of many psychiatric conditions, including depression.  
In an attempt to better elucidate the neural underpinnings of depression in youth, research 
has focused on the neurobiological correlates of the disorder.6 The integration of clinical 
phenomenology and neurobiology aims for a better understanding of mental disorders and their 
impact on affected individuals. While we are yet to translate most neuroimaging research 
findings into clinical practice, there is a large body of evidence to support the interplay between 
neural circuits and clinical depression.7 Among the most widely used neuroimaging techniques 
to observe such effects, resting-state functional magnetic resonance imaging (rs-fMRI) has been 
linked to favorable results in terms of reproducibility and consistency across studies.8 Three of 
the major circuits frequently evaluated in rs-fMRI studies of individuals with depression, defined 
as sets of brain regions that display correlated activity during rest,9 are the default mode network 
(DMN), the salience network (SN), and the cognitive control network (CCN).  
The DMN is activated during moments of passive rest and suppressed during goal-directed 
tasks.10 The network is most notably comprised of the medial prefrontal cortex (MPFC) and the 
posterior cingulate cortex (PCC), and has been consistently shown to exhibit aberrantly increased 
connectivity in individuals with depression when compared with healthy controls.11 The SN is 
associated with environmental detection of salient changes,12 and its major nodes include the 
dorsal anterior cingulate cortex (dACC) and anterior insula (AI). The CCN is implicated in 
higher order cognitive functions, and is constituted by the dorsolateral prefrontal cortex 
(DLPFC), the ACC, and the dorsal parietal cortex (DPC).13 Hypoconnectivity within and 
between the SN and CCN networks has been evidenced in individuals with depression.14 
Much of the global burden of youth depression comes from its effects on populations of 
low- and middle-income countries (LMICs), where most of the world’s youth population 
lives.1,15,16 Nevertheless, the majority of research in depression has been conducted in high 
income countries (HICs),17 a phenomenon that came to be known as the 10-90 divide – only 10% 
of the randomized clinical trials for mental health conditions affecting youth were performed in 
LMICs, where 90% of the child and adolescent population live.16 The same disparity is observed 
in the field of brain imaging. A recent bibliometric review found that among the 100 most highly 
cited neuroimaging studies in psychiatric disorders, only six had a LMIC researcher as first 
author18 (China in all cases). In Brazil, only one large neuroimaging study designed to assess 
various outcomes in terms of psychopathology with published data on youth depression is 
available.19 Considering that depression has been inversely associated with socioeconomic status 
and educational levels in both high-income3 and low- and middle-income settings,4 differences in 
the rs-fMRI connectivity patterns observed in patients with MDD in LIMCs vs. HICs might be 
expected. Understanding clinical and neurobiological characteristics of depression among 
children and adolescents living in LMICs is crucial for the overall understanding of the global 
burden of youth depression, and comparing neuroimaging findings across populations from HICs 
  
and LMICs may provide unique insights to enhance our understanding of which biological risk 
processes are relatively universal across different populations, and which are context-specific.  
Focusing on the development and applications of state-of-the-art research methods 
generally employed in HIC, the Identifying Depression Early in Adolescence (IDEA) consortium 
is a multinational initiative to improve the early identification of MDD in adolescents.1 
Researchers from Brazil, Nepal, Nigeria, the United Kingdom, and the United States are 
collaborating to devise strategies for stratifying adolescents at high- and at low-risk for 
developing depression. In focusing on LMICs for this type of multilevel research, we hope to 
reduce the existing research disparity. Studying the neurobiology of depression in youth from 
LMICs may also help to identify effects of physical and emotional deprivation, trauma, 
humanitarian crises, family history of psychopathology and lower educational levels that may 
more strongly contribute to MDD’s development and recurrence in these contexts.  
In this study, we present data showing the feasibility of implementing a complex MRI 
protocol in a LMIC country. Furthermore, we present the results of a preliminary analysis of rs-
fMRI data from 29 psychotropic medication-free adolescents with a current diagnosis of MDD. 
We structured our findings in three major sections: methodology description (in which we 
specify selection criteria, the comprehensive clinical evaluation, and the selection of 
neuroimaging parameters); MRI quality control (describing the steps taken to ensure image 
quality); and the preliminary results obtained with 29 MDD participants.  
 
Methods 
Sample and design 
The present pilot is part of a larger study that is currently in the process of data collection, 
with a projected sample of 105 adolescents who will undergo a full clinical evaluation as well as 
collection of biomarker and neuroimaging data. The data in this preliminary analysis refer to 
MDD participants recruited in the initial 6 months of the study. All participants were recruited 
from a convenience sample of 57 public state schools located near Hospital de Clínicas de Porto 
Alegre (HCPA), Brazil, where the evaluations are performed. Screening for depressive 
symptoms was performed using the Patient Health Questionnaire for Adolescents (PHQ-A),20 
with a score of 10 or higher being considered as positive screening for depression. The present 
analyses refer to 31 participants with MDD; two were excluded due to quality issues (see quality 
control criteria below), and thus the final analysis included 29 participants. 
 
Phone screening 
After the initial screening at the schools, conducted through self-administered 
questionnaires, participants were contacted over the phone for full screening to confirm 
eligibility. This phone screening phase was performed by three trained investigators to check 
participant contact information and to assess inclusion and exclusion criteria. Each adolescent 
and their primary caregiver were invited for the clinical phase of our study and, upon verbal 
assent, answered a series of structured questions over the phone. First, we inquired about the 
presence of any metal implants (i.e., braces, pacemakers, prosthetics, cochlear implants, and 
mechanical heart valves) or clinical limitations (i.e., pregnancy and claustrophobia) that would 
contraindicate MRI data collection. Second, to avoid possible confounders to the biomarker or 
neuroimaging analyses, we inquired about relevant clinical comorbidities (i.e., epilepsy, known 
brain malformations, and inflammatory disorders) and chronic use of medications (i.e., 
  
psychotropic, steroidal or non-steroidal anti-inflammatory drugs, and beta-blockers). 
Adolescents not meeting the exclusion criteria were scheduled for the clinical phase of our study. 
 
Clinical assessment 
Following the phone assessment, each adolescent came to the HCPA clinical research 
center accompanied by a primary caregiver for a comprehensive clinical evaluation performed by 
a board-certified child and adolescent psychiatrist. After being informed about the procedures, 
caregivers provided written consent and adolescents provided verbal and written assent to 
participate in the study. The protocol was approved by both the HCPA ethics committee and the 
Brazilian National Ethics Committee, (project number 50473015.9.0000.5327). 
To assess adolescents for a full range of psychiatric disorders, participants (self-report) and 
caregivers (parent-report) were independently interviewed by a board-certified child and 
adolescent psychiatrist using the Brazilian Portuguese version of the Schedule for Affective 
Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-
PL)21. Other measures included the Children’s Depression Rating Scale-Revised (CDRS-R),22 
the Children’s Global Assessment Scale (CGAS), and the Columbia-Suicide Severity Rating 
Scale (C-SSRS).23 Among the self-reported measures were the three versions (adolescent self-
report, parent-report on adolescent, and parent-report on own symptoms) of the Mood and 
Feelings Questionnaire (MFQ).24 Pubertal status was ascertained by a score of at least 2 in a self-
reported Tanner scale.25 Parents also provided thorough information on family history of mood 
disorders via a structured interview developed by our research group, covering data on the 
diagnosis of depression or bipolar disorder, history of past or current psychiatric admissions, and 
suicide attempts for all first- and second-degree family members; and completed a Brazilian 
standardized measure of socioeconomic status,26 which is a widely used set of questions about 
the ownership of house appliances, access to basic sanitation and street pavement, as well as 
family provider level of education. This validated measure of socioeconomic status in Brazil 
generates a score ranging from 0 to 100. Intelligence quotient (IQ) was estimated using the 
Wechsler Abbreviated Scale of Intelligence (WASI),27 administered by a trained psychologist. 
The full list of instruments filled out by adolescents and parents is available as Online-Only 
Supplementary Material. To confirm the diagnosis of current MDD, clinicians utilized all the 
available sources of information to generate a case formulation, which was discussed in a clinical 
committee chaired by a senior child and adolescent psychiatrist (CK). For biomarker analysis, 
blood and saliva sample were collected, and axillary temperature was measured at the time of 
blood draw. Full study inclusion and exclusion criteria for each phase are described in Table 1. 
 
Table 1 Criteria for sample composition 
Phase Inclusion criteria Exclusion criteria 
School interviews  Age 14 to 16 years Absence from school on the day of the assessment; 
inability to complete the screening questionnaire 
Phone screening  Having completed school 
questionnaire; right-
handedness 
- Metallic accessories 
- Chronic clinical conditions* 
- Use of psychotropic medication over the last 30 days 
- Use of anti-inflammatory medication over the last 14 
  
days 
Clinical 
assessment  
Intelligence quotient > 70: 
post-pubertal status: current 
major depressive disorder 
Current or lifetime: 
- bipolar disorder 
- psychotic disorder 
- autism spectrum disorder 
- substance use disorder 
- eating disorder 
- post-traumatic stress disorder 
* Excluded clinical conditions: known brain malformations, epilepsy, recent traumatic brain 
injury, diabetes, cystic fibrosis, current inflammatory disorders (i.e., asthma, rheumatologic 
conditions, and oncologic conditions), and severe neurodevelopmental disorders. 
 
Data collection 
All clinical data were collected and managed using Research Electronic Data Capture 
(REDCap) tools28 hosted at HCPA. REDCap is a secure, web-based application designed to 
support data capture for research studies, providing: 1) an intuitive interface for validated data 
entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export 
procedures for seamless data downloads to common statistical packages; and 4) procedures for 
importing data from external sources. All instruments were adapted to a digital version and 
uploaded to the REDCap database by researchers in our group. Instruments that have conditional 
branches depending on initial responses by the participants, (e.g., the K-SADS-PL) had their 
algorithms fully implemented in the REDCap system by our team, via built-in functions such as 
“branching logic.” This facilitated data collection and clinical decision-making, while reducing 
the possibility of human error in the prompt assessment of structured and semi-structured 
interviews.  
 
MRI protocol 
The last evaluation step, after clinical diagnosis of depression and biomarker collection, 
was structural and functional MRI acquisition. The ultimate aim of the protocol is to determine 
differences in brain structure and function in adolescents with MDD vs. those without MDD. For 
each participant, clinical assessment and MRI were conducted sequentially on the same day.  
A whole-brain T1-weighted anatomical scan was collected from every participant. fMRI 
was performed both in passive rest (resting-state, rs-fMRI) and during a series of tasks. Two 
different tasks were used to engage both the reward network and the emotion network: the 
gambling task, adapted and translated into Brazilian Portuguese from Barch et al.29; and  the 
emotional face matching task, adapted and translated into Brazilian Portuguese from Hariri et 
al.30 Both fMRI tasks use a block design, and block orders were counterbalanced to reduce 
potential carryover effects. In the present report, we provide initial data for the first 29 
participants with MDD adequate neuroimaging data. Structural and task-based fMRI data will be 
reported once data collection is complete. 
 
Image acquisition 
All images were acquired using a 3T Ingenia scanner (Koninklijke Philips N.V., The 
Netherlands), software version 5.3.1., purchased by HCPA in 2017 in an attempt to expand the 
  
imaging research capacity of the institution. Along with the machine, an Esys fMRI by Invivo 
with a 32" screen and console system was installed, consisting of two task-dedicated computers, 
two button boxes, a response control pad, and an MRI-compatible screen with a set of mirrors to 
be used inside the MRI room. Tasks were run in a dedicated computer using E-prime Runtime 
version 3.0. 
High-resolution structural images were collected using T1 weighted MPRAGE volumetric 
acquisition in sagittal plane with TR (repetition time) = 8.55 ms, TE (echo time) = 3.94 ms, TI 
(inversion time) = 900 ms, flip angle = 8o, field of view = 240 × 240 mm, 170 slices with 0.94 
mm thickness, acquisition matrix 256 × 256, resulting in a 0.94 × 0.94 × 0.94 mm3 voxel 
resolution. Blood oxygenation level dependent signal (BOLD) images were collected with the 
following acquisition parameters: TR = 2000 ms, TE = 30 ms, flip angle = 90°, in transaxial 
plane aligned to the anterior and posterior commissure line, field of view = 240 × 240 mm, 36 
slices with 3.5 mm thickness, slice gap 0.35 mm, and acquisition matrix 80 × 80. The gambling 
task was administered in four runs (90 volumes and 3:10 minutes each); the emotional face 
matching task was administered for one run (277 volumes and 9:24 minutes); and the resting-
state functional connectivity (rsFC) scan was administered for 6:52 minutes (206 volumes). 
During the resting state scan, participants were shown an image of a fixation cross on the screen 
and were instructed to let their minds wander. 
 
Magnetic resonance imaging (MRI) quality control 
MRI system quality is assessed weekly through Philips Imaging Quality Tool (PIQT) as 
part of the institutional MRI quality control program. It is a pass/fail automatic tool that provides 
information about the global system performance and individual evaluation for the central 
frequency (magnetic field drift), spatial linearity, imaging uniformity, spatial resolution, and 
head coil signal to noise ratio (SNR). SNR showed the highest variation among all parameters. 
All image quality parameters remained within the values specified by the manufacturer during 
data collection. 
 
Resting-state functional connectivity (rsFC) pre-processing and quality assurance 
The rsFC images were pre-processed in the Conn toolbox (https://web.conn-toolbox.org). 
Pre-processing steps included realignment and unwarping, slice-timing correction, detection of 
outlier scans, segmentation and normalization of functional images into a standard stereotaxic 
space (Montreal Neurological Institute [MNI]), and smoothing with 6 mm full width at the half 
maximum (FWHM) Gaussian kernel. BOLD images were bandpass filtered to a 0.009Hz-0.08Hz 
window. In addition, to minimize the influence of head motion on rsFC analyses, volumes were 
censored according to the conservative criteria within the Conn toolbox (any volumes exceeding 
a global-signal Z-value threshold of 3 or a 0.5 mm volume-to-volume motion threshold). 
Participants with more than 10% of volumes censored based on these criteria were excluded; this 
resulted in the removal of two participants from the data set (both had over 10% of volumes 
censored due to head motion), leaving a total of 29 participants with data meeting all quality 
control criteria. 
 
Statistical analyses 
Data analyses included a description of the sample characteristics and comparison for sex 
differences, using t tests for quantitative variables and chi-square tests for categorical variables. 
  
For rsFC, seed-to-voxel analysis was used to report connectivity within three networks 
hypothesized to play a role in depression: the DMN, the SN, and the CCN. Seeds were defined 
using the Conn toolbox’s network-based seeds and included the MPFC (DMN), the dACC (SN), 
and the right and left LPFC (CCN). RsFC images were generated for each seed and then fed into 
group-level analyses in the Conn toolbox to test whether each seed was connected with expected 
regions in its network in the pilot sample. The thresholds used to examine connectivity within 
each network were p < 0.001 for corrected voxelwise and p < 0.05 for false discovery rate 
(FDR)-corrected at the cluster-level. The results for clusters with a minimum size of 100 voxels 
are reported. 
 
Results 
Sample characteristics 
The final sample included 29 adolescents with a current diagnosis of MDD, clinical 
evaluation, and successful MRI acquisition. Sample characteristics are presented in Table 2.  
 
Table 2 Sample characteristics 
 Overall Male Female 
Age 16.01 (0.78) 16.16 (0.93) 15.93 (0.70) 
Sample size, n (%) 29 (100.00) 10 (34.48) 19 (65.52) 
    
Skin color (self-reported), n (%)    
White 16 (55.17) 6 (60.00) 10 (52.63) 
Non-white 13 (44.83) 4 (40.00) 9 (47.37) 
    
MFQ-C 41.41 (9.87) 39.89 (8.71) 42.21 (10.56) 
MFQ-P 20.66 (11.85) 24.33 (14.21) 18.74 (10.31) 
CDRS 53.34 (10.01) 49.91 (10.14) 55.16 (9.72) 
Any psychiatric comorbidity, n (%) 19 (65.52) 7 (70.00) 12 (63.16) 
WASI (IQ) score 91.48 (9.43) 97.78 (8.36) 88.16 (8.34)* 
Socioeconomic status† 35.67 (19.89) 32.22 (8.73) 37.32 (23.48) 
Parental history of mood disorder, n (%)‡ 19 (65.52) 7 (70.00) 12 (63.16) 
MFQ-A 21.90 (14.77) 20.60 (13.49) 22.58 (15.71) 
Data presented as mean (standard deviation), unless otherwise specified.  
CDRS = Children’s Depression Rating Scale; MFQ-A = Mood and Feelings Questionnaire, 
Adult Version; MFQ-C = Mood and Feelings Questionnaire, Child Version; MFQ-P = Mood and 
Feelings Questionnaire, Parent Version; WASI = Wechsler Abbreviated Scale of Intelligence.  
* p < 0.05 for the comparison between males and females. 
† Based on Kamakura et al.26 
‡ Family history of mood disorder was operationalized as history of major depressive disorder, 
bipolar disorder, or suicide attempt in any parent.  
 
 
  
In this sample, 55.17% of the adolescents reported their skin color as white. Regarding 
socioeconomic status, family income was about 16% higher than the average for the city of Porto 
Alegre (where the data were collected and the adolescents live), and around 65% higher than the 
national average income.31 Mean IQ scores were considered within the average for this age 
range, while depression symptoms were high, as expected, in both the MFQ-C and CDRS. 
Further, most participants had parental history of depression, bipolar disorder, or suicide attempt. 
Finally, about two-thirds of the sample had at least one psychiatric comorbidity, with generalized 
anxiety disorder and attention deficit hyperactivity disorder (ADHD) being the most frequent 
(seven and two affected adolescents respectively). When comparing measures between sexes, 
only WASI scores were statistically different, with boys having a higher mean than girls. The 
difference in all other measures was not statistically significant for the sex comparison. 
Interestingly, there was a significant disparity between the MFQ-C (self-report by the 
adolescents) and the MFQ-P (parent report on youth symptoms) (p < 0.05), with adolescent 
depressive symptoms largely underreported by the parents. 
 
MRI quality control 
In order to ascertain the quality of fMRI acquisition, specific items of the EPI acquisition 
were assessed, as suggested by the American Association of Physicists in Medicine (AAPM) 
Report 100 from 2010.32 These performance tests were performed every 6 months, for a total of 
two data points during the present study (immediately before and after data collection). Among 
the parameters evaluated, the means were 1.79% for ghosting ratio, 1.29% for geometric 
distortion, and 0.18% for EPI stability coefficient of variation. The maximum suggested values 
for such parameters are, respectively, 3, 3, and 0.25%. Our findings were well within the 
suggested values, which attests to the technical quality of our MRI acquisition. 
 
Resting-state functional connectivity (rsFC) 
The findings obtained for all three major networks evaluated (DMN, SN, and CCN) were 
consistent with the previous literature on HIC. In DMN, there was positive connectivity between 
the MPFC, the angular gyrus, and the PCC (Figure 1A). The SN exhibited positive connectivity 
between the ACC and AI (Figure 1B), while the right and left LPFC were positively connected 
to the DPC in the CCN (Figures 1C and 1D, respectively). See the Online-Only Supplementary 
Material for statistics and coordinates. 
 
  
 
 
Figure 1 Resting-state functional connectivity (rsFC) in three major networks of a sample of 
adolescents with major depressive disorder (n = 29). A) Default mode network showing positive 
connectivity between the medial prefrontal cortex, the angular gyrus, and the posterior cingulate 
cortex. B) Salience network exhibiting positive connectivity between the anterior cingulate 
cortex and the anterior insula. C, D) Right and left lateral prefrontal cortex, respectively, 
highlighting positive connectivity with the dorsal parietal cortex in the cognitive control 
network.  
 
Challenges and difficulties 
Considering that the present results refer to the onset of fMRI studies in our institution, a 
series of challenges had to be overcome in all steps of data collection. A large number of 
adolescents had either dental braces or a fixed retainer that is commonly placed behind the lower 
teeth after the removal of braces, and both are contraindications to undergo MRI in our 
institution. The presence of metal accessories (especially orthodontic devices) in general 
accounted for about 30% of exclusions on the phone screening. Further, we had a few issues with 
the MRI equipment during the protocol: in one case, the screen malfunctioned during MRI 
A B 
C D 
  
acquisition; the participant was unable not complete the fMRI tasks and had to be excluded. The 
reason for that was a failure in the screen power supply which had to be replaced. The usual 
replacement time of 1 month was fortunately reduced to 1 week with support from the 
institution. During this period, all data collection was interrupted. Aside from that, some minor 
technical issues (software malfunctions, power outages) had to be handled, but no data were lost. 
 
Discussion 
Depression provides an important contribution to the burden of disease in youth 
worldwide, and these effects might be even more pronounced in LMICs. Neuroimaging research 
holds the potential for elucidating the neurobiology of depression and revealing the mechanisms 
of development of risky patterns of brain function. However, there are still relatively few 
neuroimaging studies addressing this issue. Given the disparity in the volume of research 
performed in HICs as compared to LMICs, high quality research must be performed in LMICs to 
better elucidate the particular characteristics of depressed youth in these countries. 
Here, our main goal was to describe the development and application of a high-quality 
neuroimaging protocol that would still be feasible despite the financial and technical barriers 
expected in a middle-income country. We also performed a preliminary analysis of fMRI data to 
ensure that data collection and quality control standards would be comparable to those in HICs. 
Our final sample in this pilot study consisted of 29 adolescents with depression who 
underwent a comprehensive clinical evaluation (with several measures of depression and other 
psychiatric comorbidities), a collection of blood and saliva for future biomarker analysis, and a 
full MRI protocol involving structural MRI, resting-state and task-based fMRI. Only two 
participants were excluded for MRI quality issues (head movement), which is comparable to 
large neuroimaging studies in HIC.33 Further, our sample is within expected ranges for 
demographic characteristics in Brazil according to the national census,34 with both skin color and 
socioeconomic status closely related to the local population averages. As expected, participants 
exhibited high levels of depressive symptomatology in all scales. Parents largely underreported 
adolescent symptoms of depression. While this was somewhat expected given the internalizing 
nature of MDD,35 it also reinforces the importance of measuring symptoms directly with the 
adolescents for diagnosing depression using the available psychometric tools. 
Preliminary analyses of rs-fMRI data revealed patterns of resting-state connectivity 
consistent with prior research in HICs.10-12 Specifically, we observed the expected patterns of 
significant connectivity between the MPFC and PCC (DMN), the ACC and AI (SN), and the 
LPFC and DPC (CCN). These results indicate that we were able to effectively measure rs-fMRI 
within these networks in a LMIC setting, laying the foundation for future analyses to examine 
whether connectivity within these networks correlates with indices of risk for depression and 
depression severity. This will allow us to address important questions regarding which findings 
from prior research on the neurobiology of depression are relatively universal across different 
parts of the globe, and which are context-specific. 
Our study has limitations that must be addressed. First, as a pilot study, the focus was 
restricted to the feasibility of data collection and basic group data analyses. The small number of 
participants might have increased the chance of type II error. Also, we did not, at this point, run 
more complex correlations between depressive symptoms and MRI findings. Thus, the 
possibility that rsFC or the other measures varied as a function of depression severity was not 
assessed at this point, and will be analyzed once full data collection is complete. Further, since 
we are evaluating a wide range of biomarkers in our sample, there were several exclusion criteria 
  
unrelated to the neuroimaging itself that might have produced bias and reduced external validity. 
Finally, our sample had slightly higher income than the Porto Alegre average, but showed 
socioeconomic differences from the overall Brazilian population in terms of ethnicity and 
income, with a higher percentage of white and lower proportion of non-white teenagers. Brazil is 
a country with over 34 million adolescents34 living in a variety of socioeconomic contexts, and 
further studies will be required to adequately capture all the regional differences. 
Among the strengths of our study is the carefully phenotyped, psychotropic drug-free 
nature of the sample. Also, the present protocol will allow three groups of adolescents to be 
compared: participants with MDD and those at both low- and at high-risk for developing 
depression subsequently. Therefore, the present study is among the first to have fMRI data 
collected and stratified based on depression risk and clinical diagnosis among adolescents in 
LMICs, which adds to the relevance of the findings. Further, our sample had blood and saliva 
samples collected for biomarker analysis, adding to the wide array of techniques used to analyze 
multiple facets of depression. Lastly, all our data (clinical, biomarkers, and neuroimaging) were 
collected on the same day for each participant. Such a strategy fills an important gap, since most 
studies collected neuroimaging data several days/weeks after clinical evaluation. Since 
depressive symptoms usually change over the span of days or weeks, we believe more reliable 
correlations between the clinical evaluation and neuroimaging will be detected with the present 
protocol.  
 
Conclusions 
This is an important preliminary study that aims to shed light on depression in LMICs, 
where most affected individuals live. We have shown the feasibility of a complex fMRI protocol 
all the way from design to data analysis. As one of the first fMRI studies of youth depression in 
LMIC, we hope these findings will reduce the overall disparity and contribute with quality data 
on this very important group of individuals. 
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